Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
published in: Vaccine
date of publication: 2015-12-17
language: English
main subject: Rift Valley fever phlebovirus, phase II clinical trial, Rift Valley fever
Cites articles 22
Date
Title
Article - wd:Q36514844